Mitsu Chem Plast Ltd

Mitsu Chem Plast Earnings Call Transcript: Key Takeaways

Q2 revenue rose 3.7% to ₹95.8 Cr while PAT jumped ~224% on a 6.4% margin. The story is profit-led with flat volumes. The ₹1,000 Cr FY28 ambition looks stretched against a ~₹400 Cr run-rate.

Mitsu Chem Plast Investor Presentation: Key Takeaways

H1FY27 revenue Rs 19,095 Lakhs (+7% YoY), EBITDA Rs 2,738 Lakhs at 14% margin, PAT Rs 1,484 Lakhs (+365%). Strategy shifts toward hospital furniture and IBC.

Mitsu Chem Plast Earnings Call Transcript: Key Takeaways

Mitsu Chem Plast reported strong Q1 FY27 results with significant profitability expansion, driven by operational efficiencies and improved product mix. The company is targeting INR 1,000 crores revenue by FY28.

Mitsu Chem Plast Investor Presentation: Key Takeaways

Mitsu Chem Plast reported Q1 FY27 revenue of ₹95.15 Cr and PAT of ₹8.74 Cr. Strategy focuses on expanding the 'Furnastra' healthcare brand and scaling packaging solutions.

Call

Guides 200% growth